Aprinoia Therapeutics Limited
USPTO PatentsView assignee record - 6 granted patents across 6 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Aprinoia ranks #38,837 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 6 technology areas.
- #38,837
- of 49,997 US assignees by volume
- Top 22%
- by Innovation Score (46.0/100)
- 17.7
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R38837 · Foreign Corporation #38,837 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 6 grants
- LOWER-Q #38,837/49,997
- PHOTO-FINISH Applaud Medical
- CPC-NARROW A61P · 6 areas
- INNOV-PAR 46.0/100
- CLAIMS-RICH 17.7 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2021–2025 · 5y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Applaud Medical, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Aprinoia’s 46.0 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Aprinoia
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Aprinoia Therapeutics · this assignee
Aprinoia Therapeutics · this assignee
46 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Aprinoia's Innovation Score is 46.0/100 (top 22% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Aprinoia?
Each dot is one of Aprinoia’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Aprinoia’s own 17.7 claims/patent is ABOVE the 16.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Aprinoia's grants concentrate
Aprinoia Therapeutics Limited is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2022 (2 grants) versus a trough of 1 in 2021. By volume, Aprinoia sits between Applaud Medical, Inc. and Aptose Biosciences Inc..
Aprinoia's three-year grant acceleration
Aprinoia Therapeutics Limited shows 4 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Aprinoia's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Applaud Medical
Applaud Medical, Inc.
6 patents
- Applied Food Biot…
Applied Food Biotechnology, Inc.
6 patents
- Applied Lacquer I…
Applied Lacquer Industries Inc.
6 patents
- Applikate
Applikate Technologies, Inc.
6 patents
- APT Advanced Poly…
APT Advanced Polymer Technology Corp.
6 patents
- Aptamir Therapeut…
Aptamir Therapeutics, Inc.
6 patents
- Apterna
Apterna Limited
6 patents
- Aptose Biosciences
Aptose Biosciences Inc.
6 patents
- Aprinoia Therapeu… ◀
Aprinoia Therapeutics Limited
6 patents
What this shows Aprinoia holds 6 patents at rank #38,665, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Aprinoia
By rank, the assignees closest to #38,665 in granted patent volume.
- Applaud Medical, Inc. #38,661 · 6 patents
- Applied Food Biotechnology, Inc. #38,662 · 6 patents
- Applied Lacquer Industries Inc. #38,663 · 6 patents
- Applikate Technologies, Inc. #38,664 · 6 patents
- APT Advanced Polymer Technology Corp. #38,666 · 6 patents
- Aptamir Therapeutics, Inc. #38,667 · 6 patents
- Apterna Limited #38,668 · 6 patents
- Aptose Biosciences Inc. #38,669 · 6 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Aprinoia's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Aprinoia's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
46 Top 22% higher than 78% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 1 | 16.7% |
| 2022 | 2 | 33.3% |
| 2023 | 1 | 16.7% |
| 2024 | 1 | 16.7% |
| 2025partial year | 1 | 16.7% |
Which technologies does Aprinoia Therapeutics Limited patent most?
Top 6 of 6 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Aprinoia Therapeutics Limited's patent record in context - here's where to go next.
- Aprinoia Therapeutics Limited's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #38,837 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Aprinoia Therapeutics Limited against Applaud Medical, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 46.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.